Arvee Laboratories (India) Ltd. share price
Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also provides drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4amino p…Read more
- Market Cap₹ 249 Cr.
- Current Price₹ 226.20
- High / Low₹ 291 / 129
- Stock P/E61.5
- Book Value₹ 31
- Dividend Yield0.00 %
- ROCE7.2 %
- ROE7.80 %
- Face Value₹ 10.0
More figures (10)
- EPS (TTM)₹ 3.68
- Price / Book7.41
- OPM6.3 %
- Debt / Equity0.03
- Sales growth (5Y)-7.8 %
- Profit growth (5Y)-1.2 %
- Promoter holding—
- EV / EBITDA46.2
- Beta0.50
- All-time high₹ 315
Price chart
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|---|---|
| ARVEE | +34.43% | +43.16% | +38.68% | +6.03% | +38.82% | +21.54% | +20.45% |
| Nifty 50 | -0.31% | -3.85% | -4.34% | -11.42% | -9.53% | +5.46% | +4.76% |
Price returns only (dividends not included). Prices from NSE via Yahoo Finance; may be delayed.
Quick take
- Arvee Laboratories (India) Ltd. is in the Specialty Chemicals industry (Basic Materials), with a market value of ₹249 crore.
- It trades at 61.5 times its last 12 months' earnings and 7.4 times book value.
- Revenue grew -7.8% a year over the last 5 years, profit -1.2% a year.
- Return on equity was 7.8% and return on capital employed 7.2% in the latest year.
- Debt was 0.03 times shareholders' equity.
- The share price is 22.2% below its 52-week high and up 38.8% over one year.
Pros
AI- Company is almost debt-free (debt is 0.03 times equity).
- Latest quarter (Jun 2026): sales up 130% and profit up 902% from a year ago.
- Trades at 61.5 times earnings, below its 3-year median of 80.5.
- Promoters hold a large stake of 73.50%.
Cons
AI- Return on equity has been low: 6.2% on average over the last 3 years.
- Sales growth has been slow: -7.8% a year over the last 5 years.
- Profit growth has been weak: -1.2% a year over the last 5 years.
- The company has not paid a dividend recently.
Pros and cons are generated automatically from the reported figures. They are observations, not a recommendation to buy or sell.
AI analysis
Plenitude AI reads the figures on this page and explains them in plain language. It does not say whether to buy or sell.
About Arvee Laboratories (India) Ltd.
Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also provides drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4amino pyridine, and 2chloro5nitrobenzoic acid. In addition, the company exports its products. Arvee Laboratories (India) Ltd. was incorporated in 2012 and is based in Ahmedabad, India.
- Employees
- 57
- Head office
- Ahmedabad
Peer comparison
Basic MaterialsSpecialty Chemicals
| S.No. | Company | CMP ₹ | P/E | Mar Cap ₹ Cr | Div Yld % | NP Qtr ₹ Cr | Qtr Profit Var % | Sales Qtr ₹ Cr | Qtr Sales Var % | ROCE % | ROE % | P/B | OPM % | Debt / Eq | Prom. Hold. % | Sales ₹ Cr | Sales Var 3Yrs % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | Arvee Laboratories (India) | 226.20 | 61.5 | 249 | 0.00 | 2 | 901.89 | 17 | 130.28 | 7.2 | 7.8 | 7.41 | 6.3 | 0.03 | — | 32 | -7.8 |
| 2. | Asian Paints | 2,331.90 | 46.9 | 2,23,546 | 1.17 | 1,539 | 39.96 | 10,521 | 17.89 | 24.4 | 21.2 | 10.47 | 15.8 | 0.18 | 52.90 | 35,541 | 1.1 |
| 3. | Pidilite Industries | 1,502.80 | 57.8 | 1,53,066 | 0.76 | 884 | 30.29 | 4,552 | 21.27 | 28.5 | 23.8 | 14.12 | 21.6 | 0.04 | 69.28 | 14,601 | 7.4 |
| 4. | Berger Paints India | 473.95 | 45.4 | 55,263 | 0.85 | 404 | 54.30 | 3,584 | 32.53 | 20.6 | 17.2 | 7.99 | 12.6 | 0.09 | 75.60 | 11,790 | 4.2 |
| 5. | Acutaas Chemicals | 3,206.00 | 68.2 | 26,248 | 0.08 | 74 | 18.85 | 330 | 9.32 | 27.7 | 24.0 | 15.88 | 33.5 | 0.02 | 38.31 | 1,329 | 29.4 |
| 6. | Kingfa Science & Technology (India) | 6,536.00 | 39.2 | 8,857 | 0.31 | 80 | 101.57 | 689 | 49.06 | 17.9 | 17.4 | 6.33 | 12.9 | 0.01 | 74.88 | 1,996 | 12.4 |
| 7. | Polyplex Corporation | 1,000.00 | 20.2 | 3,259 | 0.20 | 171 | — | 2,254 | 29.62 | 1.0 | 1.1 | 0.74 | 2.1 | 0.22 | 56.54 | 7,086 | -2.5 |
| 8. | Apcotex Industries | 597.45 | 19.2 | 3,097 | 1.36 | 79 | 312.01 | 526 | 39.88 | 21.0 | 17.3 | 4.99 | 9.4 | 0.16 | 59.26 | 1,441 | 10.1 |
| 9. | Kronox Lab Sciences | 209.15 | 27.1 | 776 | 0.23 | 7 | 16.31 | 28 | 16.88 | 31.9 | 26.8 | 6.61 | 32.3 | 0.01 | 11.68 | 101 | 1.9 |
| 10. | Dynemic Products | 247.59 | 15.1 | 308 | 0.63 | 5 | 7.91 | 86 | -8.47 | 12.6 | 8.5 | 1.26 | 9.1 | 0.30 | 38.39 | 379 | 8.8 |
| Median: 13 Co. | 798.73 | 27.1 | 3,097 | 0.31 | 80 | 39.96 | 607 | 25.45 | 20.8 | 17.3 | 6.33 | 9.4 | 0.07 | 56.54 | 1,719 | 7.4 |
Companies in the same industry; the median covers every company in it that we hold figures for. Tap a heading to sort. Sorting and comparing are ways to explore data, not recommendations.
Quarterly Results
Standalone figures in ₹ crore
Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Latest quarter on the right.
Profit & Loss
Standalone figures in ₹ crore
Projection — your assumptions
Starts from the last four reported quarters (TTM) and applies the figures you enter; growth is pre-filled with the company's own 3-year sales growth. This is a what-if calculator for illustration, not a forecast, estimate or recommendation.
Related party transactions
Related-party transactions are dealings with promoters, directors, subsidiaries and associates. Companies disclose them to the exchanges every half-year and in detail in the notes to their annual report.
- Related Party TransactionsArvee Laboratories (India) Limited has informed the Exchange about related Party Transactions05-May-2023
- UpdatesArvee Laboratories (India) Limited has informed the Exchange regarding '1. Approve and take on record the audited consolidated financial results of the Company as per Indian Accou…26-Apr-2023
- Related Party TransactionArvee Laboratories (India) Limited has informed the Exchange about related party transaction for the period ended September 202215-Nov-2022
- Related Party TransactionArvee Laboratories (India) Limited has informed the Exchange about related party transaction for the period ended March 202204-Jun-2022
- Outcome of Board MeetingArvee Laboratories (India) Limited has informed the Exchange regarding Board meeting held on November 12, 2021. The Board has approved the results for the period ended on 30th Sep…12-Nov-2021
- Related Party TransactionsArvee Laboratories (India) Limited has informed the Exchange about related Party Transactions for the half year ended on 31.3.202128-Jun-2021
- Reply to Clarification SoughtARVEE: The Exchange has sought clarification from Arvee Laboratories (India) Limited with respect to announcement dated 26-Mar-2021, regarding sale of its entire investment in its…05-Apr-2021
- Related Party TransactionsArvee Laboratories (India) Limited has informed the Exchange about related Party Transactions04-Dec-2020
- Related Party TransactionsArvee Laboratories (India) Limited has informed the Exchange regarding Disclosure of Related Party Transaction under Regulation 23(9) of the SEBI (Listing Obligations and Disclosu…11-Dec-2019
- Related Party TransactionsArvee Laboratories (India) Limited has informed the Exchange regarding related party transactions not applicable to the company.13-Jun-2019
Full details: notes to the Financial Year 2026 annual report (related party disclosures).
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| 47 | 40 | 62 | 30 | 38 | 32 | 41 | |
| YOY Sales Growth % | -14.88% | 54.94% | -51.43% | 26.83% | -18.12% | ||
| 41 | 35 | 54 | 27 | 35 | 28 | 36 | |
| Material Cost % | 62% | 56% | 63% | 49% | 54% | 47% | 55% |
| Employee Cost % | 7% | 14% | 10% | 13% | 12% | 14% | 11% |
| Other Expenses % | 18% | 16% | 14% | 28% | 25% | 29% | 22% |
| Operating Profit | 6 | 6 | 8 | 3 | 4 | 3 | 5 |
| OPM % | 13% | 14% | 13% | 10% | 9% | 10% | 13% |
| Other Income | 1 | 0 | 0 | 1 | 1 | 1 | 1 |
| Interest | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 2 | 1 | 1 | 1 | 1 |
| Profit before tax | 4 | 3 | 6 | 2 | 3 | 2 | 5 |
| 26% | 25% | 33% | 43% | 25% | -4% | 11% | |
| Current tax | 1 | 1 | 2 | 0 | 1 | 0 | |
| Deferred tax | -0 | -0 | 0 | 0 | 0 | -0 | |
| 3 | 3 | 4 | 1 | 2 | 3 | 4 | |
| YOY Profit Growth % | -3.86% | 60.03% | -74.46% | 104.14% | 17.65% | ||
| EPS in Rs | 2.43 | 2.34 | 3.74 | 0.95 | 1.95 | 2.29 | 3.68 |
Compounded Sales Growth
- 5 Years:
- -8%
- 3 Years:
- -20%
- TTM:
- 17%
Compounded Profit Growth
- 5 Years:
- -1%
- 3 Years:
- -15%
- TTM:
- 195%
Stock Price CAGR
- 5 Years:
- 20%
- 3 Years:
- 22%
- 1 Year:
- 39%
Return on Equity
- 4 Years:
- 8%
- Last Year:
- 8%
Financial years ending March; TTM = the last four quarters. Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Dividend payout = dividends paid in the year ÷ net profit.
Balance Sheet
Consolidated figures in ₹ crore, as at 31 March
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 11 | 11 | 11 | 11 |
| Reserves | 17 | 18 | 20 | 23 |
| 1 | 1 | 1 | 1 | |
| Long term borrowings | 1 | 1 | 1 | 1 |
| 10 | 8 | 5 | 8 | |
| Trade payables | 8 | 7 | 3 | 6 |
| Current liabilities | 9 | 7 | 4 | 7 |
| Total Liabilities | 39 | 39 | 38 | 43 |
| 14 | 15 | 16 | 18 | |
| Gross block | 32 | 35 | 37 | 39 |
| Accumulated depreciation | 18 | 19 | 21 | 22 |
| Goodwill & intangibles | 0 | 0 | 0 | 0 |
| CWIP | 2 | 3 | 1 | 1 |
| 23 | 21 | 21 | 24 | |
| Inventories | 5 | 6 | 5 | 9 |
| Trade receivables | 12 | 6 | 8 | 10 |
| Cash & equivalents | 1 | 2 | 0 | 0 |
| Current assets | 22 | 17 | 20 | 25 |
| Total Assets | 39 | 39 | 38 | 43 |
Source: Yahoo Finance (compiled from the annual reports). Tap a row marked + for its breakdown.
Cash Flows
Consolidated figures in ₹ crore, financial years ending March
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 3 | 4 | -0 | -0 | |
| Profit for the year | 4 | 1 | 2 | 3 |
| Working capital changes | -4 | 1 | -3 | -3 |
| Direct taxes paid | -2 | -0 | -1 | -0 |
| -1 | -2 | -1 | 1 | |
| Fixed assets purchased | -1 | -3 | -2 | -3 |
| Fixed assets sold | 0 | 0 | ||
| Investments purchased | -9 | -8 | ||
| Investments sold | 0 | 9 | 9 | 3 |
| -2 | -0 | -0 | -0 | |
| Proceeds from borrowings | 0 | 0 | ||
| Repayment of borrowings | -2 | |||
| Interest paid | -0 | -0 | -0 | -0 |
| Net Cash Flow | -1 | 1 | -2 | 0 |
| Free Cash Flow | 1 | 1 | -2 | -3 |
Free cash flow = cash from operations − capital expenditure. Source: Yahoo Finance.
Ratios
| Ratio | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| ROE | — | 14.7% | 3.7% | 7.1% | 7.8% |
| ROCE | — | 21.6% | 6.4% | 9.0% | 7.2% |
| Operating margin | — | 8.6% | 4.9% | 6.4% | 6.3% |
| Net margin | — | 6.7% | 3.5% | 5.6% | 8.0% |
| Debt / equity | — | 0.04 | 0.03 | 0.03 | 0.03 |
| Current ratio | — | 2.44 | 2.38 | 5.14 | 3.55 |
| Debtor days | — | 73 | 74 | 80 | 121 |
| Inventory days | — | 38 | 124 | 67 | 179 |
| Days payable | — | 66 | 129 | 48 | 124 |
| Cash conversion cycle | — | 45 | 69 | 99 | 176 |
| Working capital days | — | 76 | 119 | 150 | 207 |
Computed from the reported statements: ROE on average equity; ROCE = EBIT / (total assets − current liabilities). Debtor days = receivables ÷ sales × 365; inventory and payable days use cost of goods sold; cash conversion cycle = debtor + inventory − payable days; working capital days = (current assets − current liabilities) ÷ sales × 365.
Shareholding Pattern
Numbers in percentages · as filed with NSE each quarter
- Promoters 73.50%
- Public 26.50%
| % | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 73.50% | 73.50% | 73.50% | 73.50% | 73.50% | 73.50% | 73.50% | 73.50% | 73.50% | 73.50% | 73.50% | 73.50% |
| 26.50% | 26.50% | 26.50% | 26.50% | 26.50% | 26.50% | 26.50% | 26.50% | 26.50% | 26.50% | 26.50% | 26.50% | |
| Retail (up to ₹2 lakh) | 1.90% | 1.87% | 2.05% | 2.06% | 2.07% | 2.04% | 2.02% | 1.91% | 1.96% | 1.93% | 1.88% | 1.96% |
| HNIs (above ₹2 lakh) | 24.28% | 24.28% | 24.28% | 24.28% | 24.28% | 24.28% | 24.28% | 24.28% | 24.28% | 24.28% | 24.28% | 24.28% |
| NRIs | 0.04% | 0.05% | 0.03% | 0.01% | 0.01% | 0.01% | 0.01% | 0.05% | 0.01% | 0.02% | 0.02% | 0.02% |
| Bodies corporate | 0.19% | 0.19% | 0.04% | 0.05% | 0.06% | 0.06% | 0.06% | 0.13% | 0.12% | 0.12% | 0.15% | 0.11% |
| No. of Shareholders | 1,372 | 1,298 | 1,480 | 1,416 | 1,623 | 1,576 | 1,505 | 1,505 | 1,861 | 1,638 | 1,596 | 1,947 |
Source: shareholding patterns filed by the company with NSE. Public = non-institutional holders. Tap a row marked + for its breakdown.
Documents
Announcements
- Delay/default in the payment of fines/penalties/dues etc. to authorityArvee Laboratories (India) Limited has informed the Exchange about Delay/default in the payment of fines/penalties/dues etc. to authority15-Oct-2026
- Shareholders meetingArvee Laboratories (India) Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 24, 2025. Further, the company has informed the…30-Sep-2026
- Shareholders meetingProceedings of Annual General Meeting held today that is 29th September, 202629-Sep-2026
- Trading WindowArvee Laboratories (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 201515-Sep-2026
- CessationArvee Laboratories (India) Limited has informed the Exchange regarding Cessation of Mrs Raina Singh as Company Secretary & Compliance Officer of the company w.e.f. September 09, 2…09-Sep-2026
- Outcome of Board MeetingArvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.07-Aug-2026
- CorrigendumArvee Laboratories (India) Limited has informed the Exchange regarding Corrigendum to Other04-Aug-2026
- Trading WindowArvee Laboratories (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 201527-Jun-2026
- Disclosure under SEBI Takeover RegulationsShalin Patel has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeove…15-Jun-2026
- Outcome of Board MeetingArvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.19-May-2026
- Price movementSignificant movement in price has been observed in Arvee Laboratories (India) Limited. The Exchange, in order to ensure that investors have latest relevant information about the c…15-Apr-2026
- Trading WindowArvee Laboratories (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 201527-Mar-2026
Annual reports
- Financial Year 202603-SEP-2026
- Financial Year 202530-AUG-2025
- Financial Year 202403-SEP-2024
- Financial Year 2023
- Financial Year 2022
- Financial Year 2021
Credit ratings
None filed recently.
Concalls & investor meets
None filed recently.
Filings made by the company with NSE; documents open on NSE's website.
Key dates
- Ex-dividend date
- 1 Jan 1970
- Latest quarter
- 30 Jun 2026
- Financial year end
- 31 Mar 2026
Trade with our broking desk
Open a trading & demat account through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539; NSE AP0153037862, BSE AP01095201177059). Execution and service only: no tips or research.
Latest news
From the company (NSE)
- Delay/default in the payment of fines/penalties/dues etc. to authorityArvee Laboratories (India) Limited has informed the Exchange about Delay/default in the payment of fines/penalties/dues etc. to authorityNSE filing · 15-Oct-2026
- Shareholders meetingArvee Laboratories (India) Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 24, 2025. Further, the company has informed the…NSE filing · 30-Sep-2026
- Shareholders meetingProceedings of Annual General Meeting held today that is 29th September, 2026NSE filing · 29-Sep-2026
- Trading WindowArvee Laboratories (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015NSE filing · 15-Sep-2026
- CessationArvee Laboratories (India) Limited has informed the Exchange regarding Cessation of Mrs Raina Singh as Company Secretary & Compliance Officer of the company w.e.f. September 09, 2…NSE filing · 09-Sep-2026
- Outcome of Board MeetingArvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.NSE filing · 07-Aug-2026
- CorrigendumArvee Laboratories (India) Limited has informed the Exchange regarding Corrigendum to OtherNSE filing · 04-Aug-2026
- Trading WindowArvee Laboratories (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015NSE filing · 27-Jun-2026
Headlines from news publishers (via Google News) and the filings of the company with NSE; they open on the source website. Headlines with price targets or buy/sell calls are left out. News is for information only and is not a recommendation.
Questions about Arvee Laboratories (India) Ltd.
What is the share price of Arvee Laboratories (India) Ltd. today?
What is the market cap of Arvee Laboratories (India) Ltd.?
What is the P/E ratio of Arvee Laboratories (India) Ltd.?
Is Arvee Laboratories (India) Ltd. a good investment?
How can I buy Arvee Laboratories (India) Ltd. shares?
Have a question about this topic?
Tell us a little about your situation and an expert will call you back, usually within 2 hours on business days.
Book your free wealth consultation
- 100% free
- No obligation
- Reply within 2 hours
Request received!
Thank you for trusting Plenitude Connect. An expert will contact you shortly. Please check your inbox for details.